中文 | English
Return
Total: 4 , 1/1
Show Home Prev Next End page: GO
Author:(Seiichi MIZUSHIMA)

1.Complementary Medicine & Mucosal Immunology-Recent Topics around Inflammatory Bowel Disease

Toshinori ITO ; Yasuyuki KAI ; Takumi IGURA ; Seiichi NAKAJIMA ; Toshiro NISHIDA ; Tsunekazu MIZUSHIMA ; Riichiro NEZU

Japanese Journal of Complementary and Alternative Medicine 2008;5(2):85-101

2.Comparison of efficacy of multimatrix mesalazine 4.8 g/day once-daily with other high-dose mesalazine in active ulcerative colitis: a randomized, double-blind study.

Haruhiko OGATA ; Nobuo AOYAMA ; Seiichi MIZUSHIMA ; Atsushi HAGINO ; Toshifumi HIBI

Intestinal Research 2017;15(3):368-379

3.Comparison of efficacies of once-daily dose multimatrix mesalazine and multiple-dose mesalazine for the maintenance of remission in ulcerative colitis: a randomized, double-blind study.

Haruhiko OGATA ; Akihiro OHORI ; Haruo NISHINO ; Seiichi MIZUSHIMA ; Atsushi HAGINO ; Toshifumi HIBI

Intestinal Research 2017;15(3):358-367

4.Comparison of efficacy of once daily multimatrix mesalazine 2.4 g/day and 4.8 g/day with other 5-aminosalicylic acid preparation in active ulcerative colitis: a randomized, double-blind study.

Haruhiko OGATA ; Tadashi YOKOYAMA ; Seiichi MIZUSHIMA ; Atsushi HAGINO ; Toshifumi HIBI

Intestinal Research 2018;16(2):255-266

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 4 , 1/1 Show Home Prev Next End page: GO